Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-06-21

Clinical Trial Update: Duloxetine Versus Paroxetine for Major Depression [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing duloxetine and paroxetine for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cymbalta (duloxetine)
  • PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED